In patients with OSCC of T1-3, T2-3, T2-4, T3, T3-4, N0, N1-2, N1-3, N2, N2-3, and M0 stages, elevated UFM1 expression was significantly associated with the poorer DSS in cancer patients (Figure 5). This evidence concerns the gene UFM1 and cancer.